Linus Health, an AI-driven brain health company pioneering early detection of cognitive impairment and personalized intervention, is collaborating with League, the leading healthcare consumer experience (CX) platform, to make online cognitive screening and care available to millions of Americans through private health plans. The collaboration was announced today at the Alzheimer’s Association International Conference (AAIC) taking place this week in Toronto.
Health plan portals powered by League’s CX platform can access Linus Health’s groundbreaking digital cognitive assessments along with educational content on dementia, brain health, and evidence-based interventions such as lifestyle changes. Also included is access to its ecosystem of care from Alzheimer’s disease (AD)-biomarker blood testing to telehealth services and clinical trials. This integration enables plans to embed proactive brain health support directly into their digital front door, enhancing their ability to identify at-risk members earlier, promote cognitive wellness, and scale access to personalized care pathways.
“To effectively change the trajectory of Alzheimer’s and other dementias, we must first identify individuals who are at risk but often overlooked, and connect them early to the resources that can make a real difference,” said David Bates, PhD, CEO and co-founder of Linus Health. “Our collaboration with League will help millions of health plan members access proactive assessments and equip clinicians to intervene sooner—when it matters most.”
Ninety-two percent of patients with mild cognitive impairment (MCI), a precursor of dementia, go undetected, leaving millions without access to early interventions that can delay or even prevent dementia. MCI detection generally requires an in-person screening by a clinician followed by a multi-hour evaluation by a neuropsychologist, but Linus Health’s FDA-listed, AI-powered remote assessment can help detect early signs of MCI before symptoms manifest.
“This collaboration offers an opportunity for payers to proactively address the escalating costs and profound impact of cognitive decline,” said Michael Serbinis, CEO of League. “By integrating Linus Health’s advanced MCI and dementia detection capabilities within League’s AI-powered CX platform, we will equip health plans with a scalable solution to identify at-risk members earlier, enable timely interventions, and ultimately drive significant improvements in member outcomes and population health management—while also delivering unprecedented member benefits that will improve millions of lives.”
Those attending AAIC are invited to visit Linus at booth #1219. For more information about Linus Health, connect with us here. Also, be sure to check out the research Linus Health is presenting at AAIC powered by AI-driven insights across cognition, meaning, motor function, and speech—accelerating study recruitment and enabling more equitable, personalized brain health care.
